78.94 +0.21 (0.26%)
SAN
| Trade SAN now with |
Stock Details
Last Trade:78.94 Change:+0.21 (0.26%) Prev Close:78.73 Open: 79.61 Days Range:78.22 – 80.95 52 Week Range: 62.08 - 96.82 Volume:418396 P/E: N/AEPS:0.00
View AllRecent Alerts 02/10/12
Recent Alert on 02/01/12 at 8:56am
Goldman Sachs Downgrades Banco Santander (SAN) to Sell
Goldman Sachs Downgrades Banco Santander (SAN) to Sell
Goldman Sachs downgraded Banco Santander (NYSE: SAN) to Sell with a price target of $79.40. The firm said multiples are reaching peak levels despite what should be uninspiring 4Q2011 results and a difficult growth path in 2012. For an analyst... Read More
Recent Alert on 12/07/11 at 7:54am
Banco Santander-Chile (SAN) Prices 14.74B Secondary Offering at ~$66.88/ADS; Stock to Resume at 9:30am
Banco Santander-Chile (SAN) Prices 14.74B Secondary Offering at ~$66.88/ADS; Stock to Resume at 9:30am
Recent Alert on 12/07/11 at 7:54am
Banco Santander-Chile (SAN) Prices 14.74B Secondary Offering at ~$66.88/ADS; Stock to Resume at 9:30am
Banco Santander-Chile (SAN) Prices 14.74B Secondary Offering at ~$66.88/ADS; Stock to Resume at 9:30am
Recent Alert on 12/07/11 at 7:54am
Banco Santander-Chile (SAN) Prices 14.74B Secondary Offering at ~$66.88/ADS; Stock to Resume at 9:30am
Banco Santander-Chile (SAN) Prices 14.74B Secondary Offering at ~$66.88/ADS; Stock to Resume at 9:30am
View AllRecent Press Releases
Press Release on 02/08/12 at 11:00am
Four-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Continued Improvement Across All Endpoints
Four-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Continued Improvement Across All Endpoints
Press Release on 02/08/12 at 1:30am
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
Press Release on 02/07/12 at 2:04pm
Sanofi Announces FDA Approval of SkliceĀ® Lotion for the Treatment of Head Lice
Sanofi Announces FDA Approval of SkliceĀ® Lotion for the Treatment of Head Lice
Press Release on 02/07/12 at 7:30am
Rib-X Pharmaceuticals Receives $3 Million Milestone Payment from Sanofi in the RX-04 Collaboration
Rib-X Pharmaceuticals Receives $3 Million Milestone Payment from Sanofi in the RX-04 Collaboration
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/30/12 at 5:37am
Aberdeen Asset Management's Top Buys: 2 Potential Longs, 1 To Avoid
Aberdeen Asset Management's Top Buys: 2 Potential Longs, 1 To Avoid
Blog Posts on 12/16/11 at 7:51am
Positioning For 2012: Looking Beyond The U.S. For Equity, Fixed Income Exposure
Positioning For 2012: Looking Beyond The U.S. For Equity, Fixed Income Exposure


